Mark Cuban

Current Company

Cost Plus Drugs — Founder

From Broadcast.com to the Pharmacy Counter

Mark Cuban's path from dot-com billionaire to pharmaceutical disruptor traces one of the more unusual arcs in American business. After selling Broadcast.com to Yahoo for $5.7 billion in 1999 — a deal he famously hedged by purchasing collar options on Yahoo stock — Cuban spent two decades as an investor, NBA team owner, and reality television personality. But his most impactful venture didn't come until 2022, when he launched Cost Plus Drugs, an online pharmacy that sells generic medications at manufacturer cost plus a flat 15% markup and a small pharmacist dispensing fee.

The premise behind Cost Plus Drugs is radical in its simplicity: pharmaceutical pricing in the United States is opaque by design, with pharmacy benefit managers, wholesalers, and retail pharmacies each adding markups that can inflate a drug's price by hundreds or thousands of percent above manufacturing cost. Cuban's model bypasses the entire middleman infrastructure, buying directly from manufacturers and passing those savings to consumers. A medication that might cost $300 at a retail pharmacy could sell for $5 through Cost Plus Drugs — not because Cuban is subsidizing the cost, but because the traditional supply chain was inflating it.

Making Healthcare Personal

What distinguishes Cost Plus Drugs from previous attempts to disrupt pharmaceutical pricing is Cuban's willingness to use his celebrity, media savvy, and personal wealth to wage a public campaign against the pharmacy benefit manager system. He has testified before Congress, published the actual manufacturer costs of medications on the company's website for anyone to see, and used social media to call out specific examples of price inflation — turning pharmaceutical pricing from an abstract policy issue into a consumer outrage that people can verify with a few clicks.

The company has expanded rapidly, offering over 2,000 medications and building its own manufacturing facility in Dallas to further reduce costs. Cuban has described Cost Plus Drugs as the most important thing he's ever done — more important than the Mavericks, more important than Shark Tank, more important than the fortune he made in the dot-com era. Whether the company can scale enough to force systemic change in pharmaceutical pricing remains an open question, but it has already demonstrated that transparent pricing is commercially viable and that consumers will switch pharmacies when they can see what they're actually paying for.